Evidence map›Paper›PMID 36303815›Full record

ArticleCancer research communications2022

A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women.

Xiaoliang Wang, Hongjie Chen, Pooja Middha Kapoor, Yu-Ru Su, Manjeet K Bolla, Joe Dennis, Alison M Dunning, Michael Lush, Qin Wang, Kyriaki Michailidou and 61 more

Open access · goldAbstract read
In one paragraph

Article in Cancer research communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Omics-Based Investigations of Breast Cancer.Molecules (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

71 authors at 20 institutions in 10 countries.

Xiaoliang WangDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
Hongjie ChenDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
Pooja Middha KapoorDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Yu-Ru SuPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Manjeet K BollaDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Joe DennisDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Alison M DunningDepartment of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Michael LushDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Qin WangDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Kyriaki MichailidouBiostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Paul D P PharoahDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
John L HopperCentre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Melissa C SoutheyPrecision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
Stella KoutrosDivision of Cancer Epidemiology and Genetic, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Laura E Beane FreemanDivision of Cancer Epidemiology and Genetic, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Jennifer StoneGenetic Epidemiology Group, School of Population and Global Health, University of Western Australia, Crawley, Australia.
Gad RennertDepartment of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.
Rana ShibliDepartment of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.
Rachel A MurphyCancer Control Research, BC Cancer and School of Population and Public Health, University of British Columbia, Vancouver, Canada.
Kristan AronsonPublic Health Sciences, Queen's University, Kingston, Canada.
Pascal GuénelUniversité Paris-Saclay, Inserm, CESP, Team Exposome and Heredity, Villejuif, France.
Thérèse TruongUniversité Paris-Saclay, Inserm, CESP, Team Exposome and Heredity, Villejuif, France.
Lauren R TerasDepartment of Population Science, American Cancer Society, Atlanta, GA, USA.
James M HodgeDepartment of Population Science, American Cancer Society, Atlanta, GA, USA.
Federico CanzianGenomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rudolf KaaksGenomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Volker ArndtDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Reiner HoppeDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Wing-Yee LoDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Sabine BehrensDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Arto MannermaaTranslational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
Veli-Matti KosmaTranslational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
Audrey JungDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Heiko BecherInstitute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Graham G GilesCentre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Christopher A HaimanCenter for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Gertraud MaskarinecEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Christopher ScottDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Stacey WinhamDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Jacques SimardGenomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.
Mark S GoldbergDepartment of Medicine, McGill University, Montréal, Quebec, Canada; Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Quebec, Canada.
Wei ZhengDivision of Epidemiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Jirong LongDivision of Epidemiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Melissa A TroesterLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Michael I LoveLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Cheng PengChanning Division of Network Medicine, Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA.
Rulla TamimiDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Heather EliassenDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Montserrat García-ClosasDivision of Cancer Epidemiology and Genetic, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Jonine FigueroaUsher Institute of Population Health Sciences and Informatics, University of Edinburgh Medical School, Edinburgh, UK.
Thomas AhearnDivision of Cancer Epidemiology and Genetic, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Rose YangDivision of Cancer Epidemiology and Genetic, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
D Gareth EvansDivision of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
Anthony HowellDivision of Cancer Sciences, University of Manchester, Manchester, UK.
Per HallDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Kamila CzeneDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Alicja WolkInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Dale P SandlerEpidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institute of Health, Research Triangle Park, NC, USA.
Jack A TaylorEpidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institute of Health, Research Triangle Park, NC, USA.
Anthony J SwerdlowDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Nick OrrCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
James V LaceyDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Sophia WangDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Håkan OlssonDepartments of Oncology and Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Douglas F EastonDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Roger L MilneCentre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Li HsuPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Peter KraftDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Jenny Chang-ClaudeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Sara LindströmDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
Cancer Research UK Cambridge Center · GBGerman Cancer Research Center · DENational Institutes of Health · USThe University of Melbourne · AUUniversity of Washington · USKarolinska Institutet · SEAmerican Cancer Society · USCarmel Medical Center · ILCity of Hope · USDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · DEHarvard University · USInserm · FRMayo Clinic in Florida · USNational Institute of Environmental Health Sciences · USUniversität Hamburg · DEUniversity of Eastern Finland · FIUniversity of North Carolina at Chapel Hill · USVanderbilt University Medical Center · USBrigham and Women's Hospital · USCanadian Centre for Applied Research in Cancer Control · CA

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
Integration of genetic, gene expression and environmental data to inform biological basis of mammographic densityR01CA244670 · NCI · UNIVERSITY OF WASHINGTON · PI LINDSTROEM, SARA · 2021 to 2024
$1.8M
Cancer Research UK 16561NCI NIH HHS R01 CA244670NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

Background: Genome-wide association studies (GWAS) have identified more than 200 susceptibility loci for breast cancer, but these variants explain less than a fifth of the disease risk. Although gene-environment interactions have been proposed to account for some of the remaining heritability, few studies have empirically assessed this. Methods: We obtained genotype and risk factor data from 46,060 cases and 47,929 controls of European ancestry from population-based studies within the Breast Cancer Association Consortium (BCAC). We built gene expression prediction models for 4,864 genes with a significant (P<0.01) heritable component using the transcriptome and genotype data from the Genotype-Tissue Expression (GTEx) project. We leveraged predicted gene expression information to investigate the interactions between gene-centric genetic variation and 14 established risk factors in association with breast cancer risk, using a mixed-effects score test. Results: After adjusting for number of tests using Bonferroni correction, no interaction remained statistically significant. The strongest interaction observed was between the predicted expression of the Conclusion: In this transcriptome-informed genome-wide gene-environment interaction study of breast cancer, we found no strong support for the role of gene expression in modifying the associations between established risk factors and breast cancer risk. Impact: Our study suggests a limited role of gene-environment interactions in breast cancer risk.

Indexed as

Breast NeoplasmsGene-Environment InteractionFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansRisk Factors

Identifiers

PMID36303815
PMCPMC9604427
OpenAlexW4220854540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.